Friday, 15 Feb 2019

You are here

Neuropathic Like Knee Pain

Fernandez and colleagues have shed further light on a significant subset of patients with knee pain - specifically, those with neuropathic like knee pain (NKP) that includes those with knee pain modified by central and peripheral neurologic dysfunction.

They undertook a cross-sectional study of a UK (n = 9506) postal questionnaire. Questions included KP severity (numerical rating scale) identifying those with knee pain (KP).

They found that KP was common (28.2%) amongst responders, and that nearly half of these (13.65%) qualified as NKP (i.e., 3.9% of the total population). 

NKP was based on the modified painDETECT questionnaire (PDQ) and implies either central or localised damage to the nervous system or nerve fibres around that modifies the KP experience. NKP has symptoms of pain, burning pain, tingling or prickling, mechanical and thermal hyperalgesia, allodynia, paroxysmal pain and numbness.

Those with NKP were more likely to be women and have fibromyalgia (OR=4.07). widespread pain (OR 1.93), nodal osteoarthritis (OR 1.80), injury (OR 1.50), pain catastrophising (OR 5.37) and fatigue (OR 5.37) compared with non-NKP respondents.

Their data suggest that primarily central risk factors contributed to NKP (8% central vs. 3% peripheral contributions).

Identifiying NKP and central risk factors may help modify treatment strategies.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Opioid Use in Osteoarthritis Varies by State

A study in Arthritis & Rheumatology shows that there is substantial statewide variation in rates of treatment with long‐term opioid therapy in osteoarthritis - not fully explained by differences in access to healthcare providers, varying case‐mix, or state‐level policies.

Vertebroplasty and Kyphoplasty Shown to Be Ineffective

There are approximately 750,000 new vertebral compression fractures each year in the United States, with resultant acute and chronic back pain in over one‐third of patients with vertebral fractures (VF).  Both percutaneous vertebroplasty or balloon kyphoplasty have been advocated as useful means of restoring vertebral height and strength capable of reducing pain in symptomatic patients.

FDA Panel Backs Approval of Romosuzumab for Osteoporosis

The US Food and Drug Administration’s advisory committee on Bone, Reproductive and Urologic Drugs voted Wednesday in favor of approving Amgen’s osteoporosis anti-sclerostin drug, romosozumab (Evenity) for use women with postmenopausal osteoporosis. 

Reuters reports that the panel voted 16-1 in favor of the monthly injection developed jointly by UCB.

Heberden’s Nodes Predict Knee OA Progression

Hand and knee osteoarthritis are considered to be clinically and pathogenically different and distinct, but a new study suggests that Heberden's nodes (HNs) can predict MRI‐based knee osteoarthritis (OA) progression.

An NIH study of 575 subjects included clinical examination with evaluation of HNs at baseline and knee MRI at baseline and 24‐month.

NEJM Review - Glucocorticoid-Induced Osteoporosis

Lenore Buckley and Mary Humphrey have published a nice review of glucocorticoid-induced osteoporosis (GIOP) in the NEJM.